£10 million gift to drive breakthrough new treatments for myeloma

Imperial College London will establish a new centre for myeloma research at Hammersmith Hospital, thanks to a £10 million donation. The gift, from benefactors Hugh and Josseline Langmuir, will pave the way for new and better treatments for myeloma patients and bolster Imperial's world-leading research into blood disorders. Donations such as this are truly transformative, allowing us to bring together talented people, unleash potential, and surmount some of the greatest challenges facing society. Professor Alice Gast President, Imperial College London Myeloma is a kind of blood cancer that develops in plasma cells, affecting the bones, kidneys and immune system. While treatment can prolong life, the disease is currently incurable. The new Hugh & Josseline Langmuir Centre for Myeloma Research will support pioneering research into the causes, mechanisms and treatment of myeloma and will accelerate the translation of scientific discoveries into clinical solutions. Imperial's Centre for Haematology at the College's Hammersmith Hospital Campus is one of the world's leading diagnostic and treatment centres for blood disorders.